OrigiMed
Shanghai
About OrigiMed
OrigiMed is a medical science and technology transforming company which focuses on developing new technologies and clinical applications for all types of cancer patients. By carrying out more comprehensive and high-throughput methods, leveraging wholesome bioinformatics analysis and clinical annotation, they identify cancer specific molecular markers and genomic features to guide targeted or immuno-therapy, ultimately aiming to fortify the evolution of cancer precision medicine in China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $39.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2018)
- Website: origimed.com
- Phone: +86 400-821-9890
Industries & Categories
Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/origimed-43637 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.